Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Could This be the End of Flu Shots?
CP Wire
Fri, 04/20/18 - 09:18 am
Vaxart
influenza vaccines
Daiichi Sankyo
vaccines
oral vaccines
Could This be the End of Flu Shots? - Updated
Fri, 04/20/18 - 11:52 am
Vaxart
influenza vaccines
Daiichi Sankyo
Top 5 boards for week ending March 10, 2018
CP Wire
Sun, 03/11/18 - 03:05 pm
Daiichi Sankyo
Shire
Amgen
Sanofi
AstraZeneca
3 Things In Biotech, March 8: A Tale Of 3 New Trials
Seeking Alpha
Sat, 03/10/18 - 09:26 am
biotech
clinical trials
Seattle Genetics
SGN-CD48A
Daiichi Sankyo
DS-8201
HER-positive colorectal cancer
Allena Pharmaceuticals
hyperoxaluria
Top 5 viewed boards for week ending March 3, 2018
CP Wire
Sun, 03/4/18 - 01:50 pm
cafepharma
Daiichi Sankyo
Shire
Allergan
Amgen
Sanofi
sales meeting
layoffs
Esmya
Pfizer
Celgene
M&A
Daiichi Sankyo douses a report about an AstraZeneca buyout offer
Endpoints
Thu, 08/31/17 - 09:28 am
AstraZeneca
Daiichi Sankyo
M&A
Daiichi Sankyo punts $650M collaboration pact as Charleston Labs preps a comeback attempt on spurned pain drug
Endpoints
Thu, 08/31/17 - 09:13 am
Daiichi Sankyo
Charleston Laboratories
CL-108
painkillers
Daiichi Sankyo hands off cancer drug to Boston Pharma
BioPharma Dive
Wed, 08/30/17 - 09:58 am
Boston Pharmaceuticals
Daiichi Sankyo
DS-5010
cancer
Daiichi Sankyo settles U.S. lawsuits over blood pressure drug Benicar
Reuters
Wed, 08/2/17 - 09:40 am
Daiichi Sankyo
Benicar
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
Nektar’s pitch on early cancer drug OK runs into a regulatory brick wall
Endpoints
Sat, 07/22/17 - 09:57 am
Nektar
regulatory
Onzeald
Europe
Daiichi Sankyo
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
Daiichi Sankyo sweeps out Pieris drug, 5 others in a Q1 pipeline cleanup
Endpoints
Thu, 05/11/17 - 11:41 am
Daiichi Sankyo
Pieris
DS-9001
tivantinib
Arqule
Daiichi Sankyo to invest $135M in ADC manufacturing expansion
BioPharma Dive
Fri, 04/28/17 - 10:27 am
Daiichi Sankyo
drug manufacturing
antibody-drug conjugate
Daiichi, ArQule cancer drug fails in late-stage study
BioPharma Dive
Sat, 02/18/17 - 02:43 pm
Daiichi Sankyo
Arqule
clinical trials
tivantinib
liver cancer
Daiichi shutters Japanese plant amid restructuring efforts
BioPharma Dive
Fri, 02/17/17 - 09:54 am
Daiichi Sankyo
Japan
restructuring
Daiichi Sankyo shutters another R&D center in an ongoing global overhaul
Endpoints
Fri, 02/10/17 - 10:01 am
Daiichi Sankyo
R&D
restructuring
Kite Pharma partners with Japan's Daiichi for cancer therapy
Yahoo/Reuters
Tue, 01/10/17 - 11:11 am
Kite Pharma
Japan
Daiichi Sankyo
axicabtagene ciloleucel
CAR-T
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Thu, 07/14/16 - 10:11 am
Amgen
Daiichi Sankyo
Japan
biosimilars
Daiichi Sankyo halts late-stage study of lung cancer drug
BioPharma Dive
Wed, 06/1/16 - 04:47 pm
Daiichi Sankyo
clinical trials
non-small cell lung cancer
patritumab
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »